Search

Search bills, members, committees and pages...

H.R. 742

U.S. HouseIn House Committee

Summary

H.R. 742, the PROTECTS Act of 2025, was introduced in the House on Jan 28, 2025 by Rep. Richard McCormick (R) with 39 co-sponsors. It was referred to Energy And Commerce, and last saw action on Jan 28, 2025: Referred to the House Committee on Energy and Commerce.


Record

Text

H.R. 742 has 39 co-sponsors.

hb742/introduced-in-house.txt
119 HR 742 IH: Protecting Resources Of Taxpayers to Eliminate Childhood Transgender Surgeries Act of 2025
U.S. House of Representatives
2025-01-28
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
I 119th CONGRESS 1st Session H. R. 742 IN THE HOUSE OF REPRESENTATIVES January 28, 2025 Mr. McCormick (for himself, Mr. Clyde , Mrs. Luna , Mr. Scott Franklin of Florida , Ms. Van Duyne , Mr. Fallon , Mr. Collins , Mr. Weber of Texas , Mr. Harris of Maryland , Mr. Grothman , Mr. Guest , Mr. Zinke , Mr. Babin , Mr. Moore of West Virginia , Mr. Ellzey , Mr. Norman , Mr. Webster of Florida , Mr. Arrington , Mr. Wied , Mr. Rose , Mr. Austin Scott of Georgia , Mr. Hamadeh of Arizona , Mr. Baird , Mr. Owens , Mr. Gooden , Mr. Jackson of Texas , Mr. Finstad , Mr. McGuire , Mr. Johnson of South Dakota , Mr. Ogles , and Mr. Gosar ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL
To prohibit Federal funds from being used to provide certain gender transition procedures to minors.
1.
Short title
This Act may be cited as the Protecting Resources Of Taxpayers to Eliminate Childhood Transgender Surgeries Act of 2025 or the PROTECTS Act of 2025 .
2.
Prohibiting Federal funds from being used to provide certain gender transition procedures to minors
(a)
In general
Notwithstanding any other provision of law, no Federal funds may be used or otherwise made available to provide or refer for a specified gender transition procedure to an individual under the age of 18 or to reimburse any entity for providing such a procedure to such an individual.
(b)
Specified gender transition procedure defined
(1)
In general
For purposes of this paragraph, except as provided in paragraph (2), the term specified gender transition procedure means, with respect to an individual, any of the following when performed for the purpose of intentionally changing the body of such individual to no longer correspond to their sex:
(A)
Performing any surgery, including—
(i)
castration;
(ii)
orchiectomy;
(iii)
scrotoplasty;
(iv)
vasectomy;
(v)
hysterectomy;
(vi)
oophorectomy;
(vii)
ovariectomy;
(viii)
metoidioplasty;
(ix)
penectomy;
(x)
phalloplasty;
(xi)
vaginoplasty;
(xii)
vaginectomy;
(xiii)
vulvoplasty;
(xiv)
reduction thyrochondroplasty;
(xv)
chondrolaryngoplasty;
(xvi)
mastectomy; and
(xvii)
any plastic, cosmetic, or aesthetic surgery that feminizes or masculinizes the facial or other body features of an individual.
(B)
Any placement of chest implants to create feminine breasts.
(C)
Any placement of fat or artificial implants in the gluteal region.
(D)
Administering, supplying, prescribing, dispensing, distributing, or otherwise conveying to an individual medications, including—
(i)
gonadotropin-releasing hormone (GnRH) analogues or other puberty-blocking drugs to stop or delay normal puberty; and
(ii)
testosterone, estrogen, or other androgens to an individual at doses that are supraphysiologic than would normally be produced endogenously in a healthy individual of the same age and sex.
(2)
Exception
Paragraph (1) shall not apply to the following when furnished to an individual by a health care provider with the consent of such individual’s parent or legal guardian:
(A)
Puberty suppression or blocking prescription drugs for the purpose of normalizing puberty for an individual experiencing precocious puberty.
(B)
Appropriate and medically necessary procedures or treatments to correct for—
(i)
a medically verifiable genetic disorder of sex development, including—
(I)
46,XX chromosomes with virilization;
(II)
46,XY chromosomes with undervirilization; and
(III)
both ovarian and testicular tissue;
(ii)
sex chromosome structure, sex steroid hormone production, or sex hormone action, if determined to be abnormal by a physician through genetic or biochemical testing; or
(iii)
infection, disease, injury, or disorder caused or exacerbated by a previous procedure described in paragraph (1), or a physical disorder, physical injury, or physical illness that would, as certified by a physician, place the individual in imminent danger of death or impairment of a major bodily function unless the procedure is performed, not including procedures performed for the alleviation of mental distress.
(3)
Certain terms
For purposes of this section:
(A)
Sex
The term sex , when referring to individual’s sex, shall be understood to refer to either male or female, as biologically determined.
(B)
Female
The term female , when referring to a natural person, means an individual who naturally has, had, will have, or would have, but for a developmental or genetic anomaly or historical accident, the reproductive system that at some point produces, transports, and utilizes eggs for fertilization.
(C)
Male
The term male , when referring to a natural person, means an individual who naturally has, had, will have, or would have, but for a developmental or genetic anomaly or historical accident, the reproductive system that at some point produces, transports, and utilizes sperm for fertilization.

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2025-01-28
  2. Passed House
  3. Passed Senate
  4. Conference
  5. To President
  6. Became Law

CRS Summary

The summaries are the Congressional Research Service’s, one per stage. Read them in full.

Introduced in House Jan 28, 2025

hb742/introduced-in-house.md

Shown Here:
Introduced in House (01/28/2025)

Sponsors

Rep. Richard McCormick (R) sponsors H.R. 742, and 39 members have co-sponsored it, 30 of them from the day it was introduced.

Committees

H.R. 742 went before 1 committee: Energy and Commerce.

Energy and Commerce
Energy and Commerce
Referred To · Jan 28, 2025 · 1,636 Bills

Actions

H.R. 742 has taken 2 actions since Jan 28, 2025.

ChamberAction
Jan 28, 2025
House
Introduced in House
Jan 28, 2025
House
Referred to the House Committee on Energy and Commerce.Energy and Commerce Committee

Votes

H.R. 742 has not gone to a roll call.

Titles

H.R. 742 goes by 4 titles, 2 of them short titles.

  • PROTECTS Act of 2025 — Display Title
  • PROTECTS Act of 2025 — Short Title(s) as Introduced
  • Protecting Resources Of Taxpayers to Eliminate Childhood Transgender Surgeries Act of 2025 — Short Title(s) as Introduced
  • To prohibit Federal funds from being used to provide certain gender transition procedures to minors. — Official Title as Introduced

Lobbying

2 clients hired 2 firms and 6 registered lobbyists who named H.R. 742 in 7 quarterly filings, 2025 to 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Civil Rights/Civil Liberties, Defense, Education, Family issues/Abortion/Adoption, Health Issues, Foreign Relations, Housing, Immigration.

Clients

Who paid to be heard, by how many filings named the bill.

ClientBusinessStateFirmsFilingsReported
HUMAN RIGHTS CAMPAIGNDistrict of Columbia16
FAMILY RESEARCH COUNCILDistrict of Columbia11

Firms

Registrants who filed on the bill, by filings.

RegistrantClientsFilingsReported
HUMAN RIGHTS CAMPAIGN16
FAMILY RESEARCH COUNCIL11

Lobbyists

Named on the filings that cite the bill.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

ClientRegistrantPeriodReportedDocument
HUMAN RIGHTS CAMPAIGNHUMAN RIGHTS CAMPAIGN2026 second_quarter$223.7K2nd Quarter - Report
HUMAN RIGHTS CAMPAIGNHUMAN RIGHTS CAMPAIGN2025 fourth_quarter$216.2K4th Quarter - Report
HUMAN RIGHTS CAMPAIGNHUMAN RIGHTS CAMPAIGN2025 second_quarter$204K2nd Quarter - Report
HUMAN RIGHTS CAMPAIGNHUMAN RIGHTS CAMPAIGN2025 first_quarter$193.9K1st Quarter - Report
HUMAN RIGHTS CAMPAIGNHUMAN RIGHTS CAMPAIGN2026 first_quarter$174.3K1st Quarter - Report
HUMAN RIGHTS CAMPAIGNHUMAN RIGHTS CAMPAIGN2025 third_quarter$155.6K3rd Quarter - Report
FAMILY RESEARCH COUNCILFAMILY RESEARCH COUNCIL2025 first_quarter1st Quarter - Report

Classification

The Congressional Research Service files H.R. 742 under Health, one of its 31 policy areas, and gives it 3 legislative subjects.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 742’s is Health.

hr742/policy-areas.txt
HealthAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTaxationTransportation and Public WorksWater Resources Development

Legislative Subjects

H.R. 742 carries 3 of CRS’s legislative subjects, from Child health to Surgery and anesthesia.

hr742/subjects.txt
Child healthSex, gender, sexual orientation discriminationSurgery and anesthesia

Source: congress.gov · legiscan.com